A Mucin-5B variant associated with idiopathic pulmonary fibrosis may prolong survival in the general population
Journal of Clinical Investigation · 16.11.2026 · 136 (22)
DOI: 10.1172/jci211620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.11.2026. Verfasst von Mitchell J Riley und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Howard Hughes Medical Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine.
- Department of Molecular Physiology and Biophysics, Pappajohn Biomedical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Förderung
- Howard Hughes Medical Institute
Zitieren
APA
Riley, M. J., Simmering, J. E., & Welsh, M. J. (2026). A Mucin-5B variant associated with idiopathic pulmonary fibrosis may prolong survival in the general population. Journal of Clinical Investigation, 136(22). https://doi.org/10.1172/jci211620
Vancouver
Riley MJ, Simmering JE, Welsh MJ. A Mucin-5B variant associated with idiopathic pulmonary fibrosis may prolong survival in the general population. Journal of Clinical Investigation. 2026;136(22). doi:10.1172/jci211620
BibTeX
@article{Riley2026,
author = {Riley, Mitchell J and Simmering, Jacob E and Welsh, Michael J},
title = {A Mucin-5B variant associated with idiopathic pulmonary fibrosis may prolong survival in the general population},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {22},
doi = {10.1172/jci211620}
}
EUVIMED